URO-1 is an emerging medical device company developing disposable products for office procedures in urogynecology and urology. Its inaugural product, the Repris™ Bladder Injection System, has just been cleared to market by the US FDA. It is specifically designed to help reduce complications following onabotulinumtoxinA treatment for overactive bladder (OAB) in women. Repris™ features the unique Re4m™ memory cannula platform and the Rely™ "no look" self-metering syringe.
Additional products are currently in late-stage development.
Wake Forest Innovation Quarter
101 North Chestnut, Suite 101
Winston-Salem, NC 27101